Financial Summary (All financials)
In millions, except per share items | Dec-28-13 | Dec-29-12 | Dec-31-11 | Dec-25-10 | Dec-26-09 | Dec-27-08 | Dec-29-07 |
Revenues | 202.3 | 203.9 | 107.8 | 91.1 | 70.5 | 68.4 | 53.4 |
Revenue growth | -0.8% | 89.2% | 18.3% | 29.1% | 3.2% | 27.9% | |
Cost of goods sold | 120.9 | 124.1 | 71.0 | 49.5 | 43.6 | 71.1 | 55.9 |
Gross profit | 81.4 | 79.8 | 36.8 | 41.6 | 26.9 | -2.7 | -2.4 |
Gross margin | 40.2% | 39.1% | 34.2% | 45.6% | 38.1% | -4.0% | -4.6% |
Selling, general and administrative | 43.1 | 37.0 | 23.3 | 18.9 | 14.7 | 15.2 | 13.6 |
Research and development | 42.2 | 34.1 | 22.7 | 18.0 | 17.1 | 19.4 | 17.2 |
EBIT | -3.9 | 8.7 | -9.2 | 4.6 | -5.0 | -37.3 | -33.2 |
EBIT margin | -1.9% | 4.3% | -8.5% | 5.1% | -7.0% | -54.6% | -62.2% |
Pre-tax income | -4.0 | 7.2 | -9.5 | 3.9 | -7.4 | -35.7 | -33.0 |
Income taxes | 0.1 | -0.1 | 0.2 | 0.1 | 0.0 | 0.3 | 0.1 |
Tax rate | | | | 3.8% | | | |
Net income | -4.1 | 2.8 | -9.7 | 3.8 | 0.0 | 0.0 | 0.0 |
Net margin | -2.0% | 1.4% | -9.0% | 4.1% | 0.0% | -0.1% | -0.1% |
|
Diluted EPS | ($0.13) | $0.15 | ($3.57) | $1.50 | ($0.46) | ($2.32) | ($2.26) |
Shares outstanding (diluted) | 32.3 | 18.7 | 2.7 | 2.5 | 0.0 | 0.0 | 0.0 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|